Translational Medicine Centre

StartSupporting structures descriptionTranslational Medicine Centre

Translational Medicine Centre


fot. Zbigniew Wszeborowski/MUG
fot. Zbigniew Wszeborowski/MUG

In order to achieve innovative interdisciplinary projects focused on personalised medicine, MUG has established the Translational Medicine Centre (TMC) in 2019. Tasks are fulfilled in the Centre through the application of the concept of translational medicine, which is understood as the method of the fast transfer of knowledge gained in an experiment to the daily clinical practice. For the purposes of TMC, adequate new infrastructure has been provided, including operating seats for leading clinical research, imaging laboratories using the high-tech methods of magnetic resonance, laboratory places, and office and commercial places for innovative actions. The more effective transfer of knowledge is to be fostered through the proximity of the Technology Transfer Office (TTO) of MUG in the same location.

TMC is situated in the University Clinical Centre (UCC), next to the modern clinical hospitals: CIM and CNIM. At the first stage, a modern imaging centre of cardiovascular system was opened with back-up facilities (co-working space), which enables the joint labour of representatives of different scientific groups and the Technology Transfer Office. Consecutive phases are to include the establishment of Imaging Laboratory, Function Laboratory, Clinical Trial Laboratory, Advanced Medical Analysis Laboratory, GLP Cell and Tissue Culture Laboratory, and GLP Drug Technology and Analysis Laboratory. Finally, it will be the seat also for the Bioinformation and Biostatistical Laboratory, Medical Bioengineering Laboratory as well as laboratory and offices spaces to let.

The Chairman of the TMC Scientific Council is Prof. Krzysztof Narkiewicz. TMC is the place where the word ‘cooperation’ has special value and importance. In areas to gathering the best and high-tech equipment in one place, which as a core-facility will assist not individuals but all staffs who want to implement their innovative scientific projects, it is possible to optimally practice the scattered potential of individual research groups in the Priority Research Areas (PRA) strategic for the MUG.

Experts who appreciate international recognition and are directly involved in the TMC activity are Prof. Paul Grundeman from the Utrecht University and Prof. Anna Dominiczak, Vice-Director and Manager of College of Medical, Veterinary and Life Sciences, University of Glasgow. They support MUG in its effort on the further development of TMC, sharing their rich experience in the application of a concept of personalised medicine in clinical practice.